Current Protein Identity:P81511 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1DTD CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LEECH CARBOXYPEPTIDASE INHIBITOR AND THE HUMAN CARBOXYPEPTIDASE A2 (LCI-CPA2) Deposited 2000-01-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 20–80(61 aa)
Not recorded ZN ZINC ION × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;298 K;ammonium phosphate, sodium citrate, pH 7.5, VAPOR DIFFUSION, temperature 298.0K
Resolution 1.65 Å R-free 0.234
1DTV NMR STRUCTURE OF THE LEECH CARBOXYPEPTIDASE INHIBITOR (LCI) Deposited 2000-01-13 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 15–81(67 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 20mM Tris;Pressure ambient
NMR sample composition 1 mM in 20 mM phosphate buffer, pH 6.5 | 90% H2O/10% D2O
Resolution not provided
1ZFI Solution structure of the leech carboxypeptidase inhibitor Deposited 2005-04-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 16–81(66 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 3.5;300 K;Ionic strength (raw mmCIF value) 20mM phosphate buffer;Pressure ambient
NMR sample composition 1mM 15N-labeled leech carboxypeptidase inhibitor; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition 1mM 15N-labeled leech carboxypeptidase inhibitor; 100% D2O | 100% D2O
Resolution not provided
1ZFL Solution structure of III-A, the major intermediate in the oxidative folding of leech carboxypeptidase inhibitor Deposited 2005-04-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 16–81(66 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 3.5;300 K;Ionic strength (raw mmCIF value) 20mM phosphate buffer;Pressure ambient
NMR sample composition 1mM 15N-labeled III-A intermediate; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition 1mM 15N-labeled III-A intermediate; 100% D2O | 100% D2O
Resolution not provided
2ABZ Crystal structure of C19A/C43A mutant of leech carboxypeptidase inhibitor in complex with bovine carboxypeptidase A Deposited 2005-07-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain C 16–81(66 aa)
Chain D 16–81(66 aa)
Chain E 16–81(66 aa)
Chain F 16–81(66 aa)
Mutation:C19A/C43A Mutation:C19A/C43A Mutation:C19A/C43A Mutation:C19A/C43A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;1.5M Lithium Sulfate monohydrate, 100mM Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.16 Å R-free 0.234